BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 24501712)

  • 1. Esophageal tolerance to high-dose stereotactic radiosurgery.
    Lee BM; Chang SK; Ko SY; Yoo SH; Shin HS
    Radiat Oncol J; 2013 Dec; 31(4):234-8. PubMed ID: 24501712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Esophageal toxicity from high-dose, single-fraction paraspinal stereotactic radiosurgery.
    Cox BW; Jackson A; Hunt M; Bilsky M; Yamada Y
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e661-7. PubMed ID: 22572079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of cervicothoracic region stereotactic spine radiosurgery on adjacent organs at risk.
    Sharma M; Bennett EE; Rahmathulla G; Chao ST; Koech HK; Gregory SN; Emch T; Magnelli A; Meola A; Suh JH; Angelov L
    Neurosurg Focus; 2017 Jan; 42(1):E14. PubMed ID: 28041323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Esophageal tolerance to high-dose stereotactic ablative radiotherapy.
    Abelson JA; Murphy JD; Loo BW; Chang DT; Daly ME; Wiegner EA; Hancock S; Chang SD; Le QT; Soltys SG; Gibbs IC
    Dis Esophagus; 2012; 25(7):623-9. PubMed ID: 22168251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spine radiosurgery: a dosimetric analysis in 124 patients who received 18 Gy.
    Schipani S; Wen W; Jin JY; Kim JK; Ryu S
    Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):e571-6. PubMed ID: 22975607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Detailed Dosimetric Analysis of Spinal Cord Tolerance in High-Dose Spine Radiosurgery.
    Katsoulakis E; Jackson A; Cox B; Lovelock M; Yamada Y
    Int J Radiat Oncol Biol Phys; 2017 Nov; 99(3):598-607. PubMed ID: 29280455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of radiation-induced esophageal toxicity in patients with non-small-cell lung cancer treated with three-dimensional conformal radiotherapy.
    Singh AK; Lockett MA; Bradley JD
    Int J Radiat Oncol Biol Phys; 2003 Feb; 55(2):337-41. PubMed ID: 12527046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting High-Grade Esophagus Toxicity After Treating Central Lung Tumors With Stereotactic Radiation Therapy Using a Normal Tissue Complication Probability Model.
    Duijm M; van der Voort van Zyp NC; van de Vaart P; Oomen-de Hoop E; Mast ME; Hoogeman MS; Nuyttens JJ
    Int J Radiat Oncol Biol Phys; 2020 Jan; 106(1):73-81. PubMed ID: 31499137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Five-Year Outcomes of High-Dose Single-Fraction Spinal Stereotactic Radiosurgery.
    Moussazadeh N; Lis E; Katsoulakis E; Kahn S; Svoboda M; DiStefano NM; McLaughlin L; Bilsky MH; Yamada Y; Laufer I
    Int J Radiat Oncol Biol Phys; 2015 Oct; 93(2):361-7. PubMed ID: 26232858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Esophageal dose tolerance to hypofractionated stereotactic body radiation therapy: risk factors for late toxicity.
    Stephans KL; Djemil T; Diaconu C; Reddy CA; Xia P; Woody NM; Greskovich J; Makkar V; Videtic GM
    Int J Radiat Oncol Biol Phys; 2014 Sep; 90(1):197-202. PubMed ID: 25015204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeat stereotactic radiosurgery as salvage therapy for locally recurrent brain metastases previously treated with radiosurgery.
    McKay WH; McTyre ER; Okoukoni C; Alphonse-Sullivan NK; Ruiz J; Munley MT; Qasem S; Lo HW; Xing F; Laxton AW; Tatter SB; Watabe K; Chan MD
    J Neurosurg; 2017 Jul; 127(1):148-156. PubMed ID: 27494815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term Outcomes After Stereotactic Radiosurgery for Spine Metastases: Radiation Dose-Response for Late Toxicity.
    Ling DC; Flickinger JC; Burton SA; Heron DE; Quinn AE; Bejjani GK; Engh JA; Gerszten PC; Amankulor NM; Vargo JA
    Int J Radiat Oncol Biol Phys; 2018 Jul; 101(3):602-609. PubMed ID: 29678526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low Incidence of Esophageal Toxicity After Lung Stereotactic Body Radiation Therapy: Are Current Esophageal Dose Constraints Too Conservative?
    Yau V; Lindsay P; Le L; Lau A; Wong O; Glick D; Bezjak A; Cho BCJ; Hope A; Sun A; Giuliani M
    Int J Radiat Oncol Biol Phys; 2018 Jul; 101(3):574-580. PubMed ID: 29680259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors affecting survival in 37 consecutive patients undergoing de novo stereotactic radiosurgery for contiguous sites of vertebral body metastasis from renal cell carcinoma.
    Sellin JN; Reichardt W; Bishop AJ; Suki D; Rhines LD; Settle SH; Brown PD; Li J; Rao G; Chang EL; Tatsui CE
    J Neurosurg Spine; 2015 Jan; 22(1):52-9. PubMed ID: 25360530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases ≥ 2 cm.
    Angelov L; Mohammadi AM; Bennett EE; Abbassy M; Elson P; Chao ST; Montgomery JS; Habboub G; Vogelbaum MA; Suh JH; Murphy ES; Ahluwalia MS; Nagel SJ; Barnett GH
    J Neurosurg; 2018 Aug; 129(2):366-382. PubMed ID: 28937324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes and toxicity for hypofractionated and single-fraction image-guided stereotactic radiosurgery for sarcomas metastasizing to the spine.
    Folkert MR; Bilsky MH; Tom AK; Oh JH; Alektiar KM; Laufer I; Tap WD; Yamada Y
    Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):1085-91. PubMed ID: 24661662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local disease control for spinal metastases following "separation surgery" and adjuvant hypofractionated or high-dose single-fraction stereotactic radiosurgery: outcome analysis in 186 patients.
    Laufer I; Iorgulescu JB; Chapman T; Lis E; Shi W; Zhang Z; Cox BW; Yamada Y; Bilsky MH
    J Neurosurg Spine; 2013 Mar; 18(3):207-14. PubMed ID: 23339593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normal tissue complication probability estimation by the Lyman-Kutcher-Burman method does not accurately predict spinal cord tolerance to stereotactic radiosurgery.
    Daly ME; Luxton G; Choi CY; Gibbs IC; Chang SD; Adler JR; Soltys SG
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):2025-32. PubMed ID: 21531516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reirradiation of the spine with stereotactic radiosurgery: Efficacy and toxicity.
    Boyce-Fappiano D; Elibe E; Zhao B; Siddiqui MS; Lee I; Rock J; Ryu S; Siddiqui F
    Pract Radiat Oncol; 2017; 7(6):e409-e417. PubMed ID: 28673511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-Response Modeling of the Visual Pathway Tolerance to Single-Fraction and Hypofractionated Stereotactic Radiosurgery.
    Hiniker SM; Modlin LA; Choi CY; Atalar B; Seiger K; Binkley MS; Harris JP; Liao YJ; Fischbein N; Wang L; Ho A; Lo A; Chang SD; Harsh GR; Gibbs IC; Hancock SL; Li G; Adler JR; Soltys SG
    Semin Radiat Oncol; 2016 Apr; 26(2):97-104. PubMed ID: 27000505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.